These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 6475775

  • 1. Amiodarone: correlation of serum concentration with suppression of complex ventricular ectopic activity.
    Mostow ND, Rakita L, Vrobel TR, Noon DL, Blumer J.
    Am J Cardiol; 1984 Sep 01; 54(6):569-74. PubMed ID: 6475775
    [Abstract] [Full Text] [Related]

  • 2. Amiodarone: intravenous loading for rapid suppression of complex ventricular arrhythmias.
    Mostow ND, Rakita L, Vrobel TR, Noon D, Blumer J.
    J Am Coll Cardiol; 1984 Jul 01; 4(1):97-104. PubMed ID: 6736461
    [Abstract] [Full Text] [Related]

  • 3. Rapid suppression of complex ventricular arrhythmias with high-dose oral amiodarone.
    Mostow ND, Vrobel TR, Noon D, Rakita L.
    Circulation; 1986 Jun 01; 73(6):1231-8. PubMed ID: 3698254
    [Abstract] [Full Text] [Related]

  • 4. Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone.
    Vazquez Blanco M, Milei J, Piñeiro DJ, Buceta JE, Dreyer MP.
    Acta Cardiol; 1983 Jun 01; 38(2):125-32. PubMed ID: 6603085
    [Abstract] [Full Text] [Related]

  • 5. Chronic effects of amiodarone in patients with refractory ventricular tachycardia.
    Saksena S, Rothbart ST, Cappello G.
    Int J Cardiol; 1983 Jun 01; 3(3):339-52. PubMed ID: 6347914
    [Abstract] [Full Text] [Related]

  • 6. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A, Adragão P, Bonhorst D, Seabra-Gomes R.
    Rev Port Cardiol; 1990 Jan 01; 9(1):33-9. PubMed ID: 1691653
    [Abstract] [Full Text] [Related]

  • 7. Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone.
    Sokoloff NM, Spielman SR, Greenspan AM, Rae AP, Brady PM, Kay HR, Horowitz LN.
    J Am Coll Cardiol; 1986 Apr 01; 7(4):938-41. PubMed ID: 3958353
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.
    Nademanee K, Singh BN, Hendrickson JA, Reed AW, Melmed S, Hershman J.
    Circulation; 1982 Jul 01; 66(1):202-11. PubMed ID: 7083508
    [Abstract] [Full Text] [Related]

  • 9. [Amiodarone therapy--behavior of serum and fatty tissue concentrations].
    Gonska BD, Bethge KP, Wagner H, Bosse K, Köbberling J, Quentin CD, Kreuzer H.
    Klin Wochenschr; 1986 Mar 03; 64(5):219-26. PubMed ID: 3702280
    [Abstract] [Full Text] [Related]

  • 10. Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.
    Escoubet B, Coumel P, Poirier JM, Maison-Blanche P, Jaillon P, Leclercq JF, Menasche P, Cheymol G, Piwnica A, Lagier G.
    Am J Cardiol; 1985 Mar 01; 55(6):696-702. PubMed ID: 3976511
    [Abstract] [Full Text] [Related]

  • 11. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia.
    Saksena S, Rothbart ST, Shah Y, Cappello G.
    Am J Cardiol; 1984 Aug 01; 54(3):347-52. PubMed ID: 6465016
    [Abstract] [Full Text] [Related]

  • 12. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A, Massacci C, Curzi G, Pigini G, Costantini C, Bilancini A, Blandini A.
    G Ital Cardiol; 1986 May 01; 16(5):417-26. PubMed ID: 3732727
    [Abstract] [Full Text] [Related]

  • 13. Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.
    Rotmensch HH, Belhassen B, Swanson BN, Shoshani D, Spielman SR, Greenspon AJ, Greenspan AM, Vlasses PH, Horowitz LN.
    Ann Intern Med; 1984 Oct 01; 101(4):462-9. PubMed ID: 6476633
    [Abstract] [Full Text] [Related]

  • 14. Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study.
    Naccarelli GV, Fineberg NS, Zipes DP, Heger JJ, Duncan G, Prystowsky EN.
    J Am Coll Cardiol; 1985 Oct 01; 6(4):814-21. PubMed ID: 3928727
    [Abstract] [Full Text] [Related]

  • 15. Right and left ventricular function during chronic amiodarone therapy.
    Sheldon RS, Mitchell LB, Duff HJ, Wyse DG, Manyari DE.
    Am J Cardiol; 1988 Oct 01; 62(10 Pt 1):736-40. PubMed ID: 3421174
    [Abstract] [Full Text] [Related]

  • 16. [Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels].
    Nitsch J, Lüderitz B.
    Dtsch Med Wochenschr; 1984 Mar 30; 109(13):492-5. PubMed ID: 6423357
    [Abstract] [Full Text] [Related]

  • 17. Amiodarone in refractory life-threatening ventricular arrhythmias.
    Nademanee K, Singh BN, Hendrickson J, Intarachot V, Lopez B, Feld G, Cannom DS, Weiss JL.
    Ann Intern Med; 1983 May 30; 98(5 Pt 1):577-84. PubMed ID: 6846970
    [Abstract] [Full Text] [Related]

  • 18. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B, Garan H, Malacoff RF, DiMarco JP, Grant G, Sellers TD, Ruskin JN.
    Am J Cardiol; 1984 Jun 01; 53(11):1558-63. PubMed ID: 6731300
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
    Somani P, Simon VA, McManus K.
    Can J Cardiol; 1985 Jan 01; 1(1):56-65. PubMed ID: 3850764
    [Abstract] [Full Text] [Related]

  • 20. Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading.
    Kim SG, Mannino MM, Chou R, Roth S, Roth JA, Desai B, Ferrick KJ, Fisher JD.
    Ann Intern Med; 1992 Aug 01; 117(3):197-201. PubMed ID: 1616213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.